DGX · Quest Diagnostics Inc · Webcasts, Transcripts & Audio
$254.74
-0.94 (-0.37%)
At close · Nov 5
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$28.13B
Shares
110.02M
Volume · Nov 5
969.56K
Avg daily vol (3M)
1M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Quest Diagnostics Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Quest Diagnostics Inc (DGX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-10-22
Quest Diagnostics Inc (DGX) Q3 2026 Earnings Call Transcript
Confident tone
PAMA reimbursement headwind
Broad-based revenue and earnings growth
Automation, AI and productivity
Revenue
$3.10B
▲ 10% YoY Diluted EPS
$2.78
▲ 28.7% YoY Gross margin
33.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-14
Quest Diagnostics Inc (DGX) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-23
Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Transcript
Confident tone
PAMA, Results Act and reimbursement risk
Advanced diagnostics and clinical areas
Alzheimer's biomarker reimbursement
Revenue
$3.04B
▲ 10.2% YoY Diluted EPS
$2.84
▲ 15% YoY Gross margin
33.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-21
Quest Diagnostics Inc (DGX) Q1 2026 Earnings Call Transcript
Confident tone
Consumer Health and QuestHealth
AI and Automation Deployment
Organic Revenue Growth
Revenue
$2.90B
▲ 9.2% YoY Diluted EPS
$2.24
▲ 15.5% YoY Gross margin
32.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Transcript
Positive tone
Weather impact and seasonality
PAMA reimbursement delay and structural risk
Health plan access and Elevance share gains
Revenue
$2.81B*
▲ 7.1% YoY Gross margin
32.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Transcript
Confident tone
Consumer channel momentum
Project Nova and QARA investments
Acquisitions as growth driver
Revenue
$2.82B
▲ 13.2% YoY Diluted EPS
$2.16
▲ 8.5% YoY Gross margin
33.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-22
Quest Diagnostics Inc (DGX) Q2 2025 Earnings Call Transcript
Confident tone
Organic revenue growth and utilization
Acquisitions as growth driver
Raised full-year guidance
Revenue
$2.76B
▲ 15.2% YoY Diluted EPS
$2.47
▲ 21.7% YoY Gross margin
34.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-22
Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Transcript
Positive tone
Revenue growth and organic performance
Guidance reaffirmation and EPS cadence
Labor and expense management
Revenue
$2.65B
▲ 12.1% YoY Diluted EPS
$1.94
▲ 12.8% YoY Gross margin
32.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-30
Quest Diagnostics Inc (DGX) Q4 2024 Earnings Call Transcript
Confident tone
Acquisitions Strategy
Revenue Growth and Financial Performance
Advanced Diagnostics and Specialty Testing
Revenue
$2.62B*
▲ 14.6% YoY Gross margin
32.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-22
Quest Diagnostics Inc (DGX) Q3 2024 Earnings Call Transcript
Confident tone
Acquisitions and M&A Growth
PAMA / Medicare Reimbursement Risk
Hospital and Health System Partnerships
Revenue
$2.49B
▲ 8.4% YoY Diluted EPS
$1.99
▲ 1.5% YoY Gross margin
32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-23
Quest Diagnostics Inc (DGX) Q2 2024 Earnings Call Transcript
Confident tone
Acquisitions and M&A pipeline
Advanced diagnostics growth
Operational improvement via automation and AI
Revenue
$2.40B
▲ 2.5% YoY Diluted EPS
$2.03
▼ 1% YoY Gross margin
33.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-23
Quest Diagnostics Inc (DGX) Q1 2024 Earnings Call Transcript
Confident tone
Advanced Diagnostics portfolio expansion
Invigorate initiative / automation and AI productivity
Base business revenue growth and momentum
Revenue
$2.37B
▲ 1.5% YoY Diluted EPS
$1.72
▼ 3.4% YoY Gross margin
32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-01
Quest Diagnostics Inc (DGX) Q4 2023 Earnings Call Transcript
Confident tone
Base business revenue growth and 2023 results
M&A and hospital outreach acquisitions
Regulatory and reimbursement environment (PAMA, LDTs, FDA)
Revenue
$2.29B*
▼ 1.9% YoY Gross margin
32.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-24
Quest Diagnostics Inc (DGX) Q3 2023 Earnings Call Transcript
Revenue
$2.29B
▼ 7.7% YoY Diluted EPS
$1.96
▼ 9.7% YoY Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Quest Diagnostics Inc (DGX) Q2 2023 Earnings Call Transcript
Revenue
$2.34B
▼ 4.7% YoY Diluted EPS
$2.05
▲ 4.6% YoY Gross margin
33.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
Quest Diagnostics Inc (DGX) Q1 2023 Earnings Call Transcript
Revenue
$2.33B
▼ 10.7% YoY Diluted EPS
$1.78
▼ 39% YoY Gross margin
33.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-02
Quest Diagnostics Inc (DGX) Q4 2022 Earnings Call Transcript
Revenue
$2.33B*
▼ 15% YoY Gross margin
32.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-20
Quest Diagnostics Inc (DGX) Q3 2022 Earnings Call Transcript
Revenue
$2.49B
▼ 10.4% YoY Diluted EPS
$2.17
▼ 46% YoY Gross margin
34.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Quest Diagnostics Inc (DGX) Q2 2022 Earnings Call Transcript
Revenue
$2.45B
▼ 3.8% YoY Diluted EPS
$1.96
▼ 60.5% YoY Gross margin
34.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-21
Quest Diagnostics Inc (DGX) Q1 2022 Earnings Call Transcript
Revenue
$2.61B
▼ 4% YoY Diluted EPS
$2.92
▼ 15.6% YoY Gross margin
37.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-03
Quest Diagnostics Inc (DGX) Q4 2021 Earnings Call Transcript
Revenue
$2.74B*
▼ 8.6% YoY Gross margin
37.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-21
Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript
Revenue
$2.77B
▼ 0.4% YoY Diluted EPS
$4.02
▼ 2.9% YoY Gross margin
39.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-22
Quest Diagnostics Inc (DGX) Q2 2021 Earnings Call Transcript
Revenue
$2.55B
▲ 39.6% YoY Diluted EPS
$4.96
▲ 264.7% YoY Gross margin
38.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-22
Quest Diagnostics Inc (DGX) Q1 2021 Earnings Call Transcript
Revenue
$2.72B
▲ 49.3% YoY Diluted EPS
$3.46
▲ 374% YoY Gross margin
40.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Quest Diagnostics Inc (DGX) Q4 2020 Earnings Call Transcript
Revenue
$3.00B
▲ 55.9% YoY Diluted EPS
$4.21
▲ 126.3% YoY Gross margin
42.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-22
Quest Diagnostics Inc (DGX) Q3 2020 Earnings Call Transcript
Revenue
$2.79B
▲ 42.4% YoY Diluted EPS
$4.14
▲ 165.4% YoY Gross margin
43.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Quest Diagnostics Inc (DGX) Q2 2020 Earnings Call Transcript
Revenue
$1.83B
▼ 6.5% YoY Diluted EPS
$1.36
▼ 18.1% YoY Gross margin
33.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-22
Quest Diagnostics Inc (DGX) Q1 2020 Earnings Call Transcript
Revenue
$1.82B
▼ 3.6% YoY Diluted EPS
$0.73
▼ 39.2% YoY Gross margin
30.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-30
Quest Diagnostics Inc (DGX) Q4 2019 Earnings Call
Revenue
$1.93B
▲ 4.7% YoY Diluted EPS
$1.86
▲ 102.2% YoY Gross margin
34.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–29 of 29 webcasts
Key facts
CIK
1022079
CUSIP
74834L100
13F (30d)
604 filings
555 filers
Visit website
Investor relations